Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CCM - Concord Medical Services - ADR


IEX Last Trade
6.355
-0.185   -2.911%

Share volume: 32,200
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$6.54
-0.19
-2.83%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-6.48%
1 Month
-0.15%
3 Months
7.56%
6 Months
29.57%
1 Year
-53.31%
2 Year
-66.72%
Key data
Stock price
$6.36
P/E Ratio 
0.00
DAY RANGE
$6.36 - $7.76
EPS 
$0.00
52 WEEK RANGE
$3.82 - $26.70
52 WEEK CHANGE
-$0.52
MARKET CAP 
18.272 M
YIELD 
N/A
SHARES OUTSTANDING 
2.815 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,403
AVERAGE 30 VOLUME 
$12,094
Company detail
CEO:
Region: US
Website: concordmedical.com
Employees: 6
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry:
Sector:

concord medical services holdings limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the people's republic of china. the company operates in network and hospital segments. the company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. it also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. in addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical resear

Recent news